PTGS2 and prostate intraepithelial neoplasia: In tumor areas, percentage of coverage by COX2+ cells was significantly higher in intermediate (1.31 ± 0.51%, p < 0.0001) and advanced prostate carcinoma (1.41 ± 0.31%, p < 0.0001), compared to PIN (0.40 ± 0.13%).